The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the effect of glucagon-like peptide-1 on cardiac output and
transpulmonary gradient in patients undergoing right heart catheterisation for clinical
reasons.